Alliance Pharmaceutical Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alliance Pharmaceutical

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: All Mtn Ski who wrote (489)	8/15/2000 8:40:47 PM
From: All Mtn Ski	Read Replies (1) of 548

More coverage: RESEARCH ALERT - UBS Warburg starts Alliance Pharmaceutical NEW YORK, Aug 15 (Reuters) - UBS Warburg said on Tuesday it started coverage of Alliance Pharmaceutical Corp. (NasdaqNM:ALLP - news) as a strong buy and set a $20 price target. In a research note, analyst Jason Wittes said: -- estimates fourth-quarter earnings per share (EPS) of a loss of 38 cents. -- estimates 2004 earnings per share of $1.28 (second year of profitability).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next